Aptus Pharma Complete Financial Statements

APPL • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2025 - 2023

Complete Financial Data Export

Export complete financial statements for Aptus Pharma (APPL). Downloads include all available records across all periods. For market performance, see the APPL stock price today .

Profitability Ratios

Net Profit Margin 12.00% 2025 data
EBITDA Margin 20.00% 2025 data
Operating Margin 20.00% 2025 data
Return on Assets 13.64% 2025 data
Return on Equity 42.86% 2025 data

Balance Sheet Ratios

Current Ratio 6.67 2025 data
Debt to Equity 3.14 2025 data
Equity Ratio 31.82% 2025 data
Asset Turnover 1.14 2025 data

Year-over-Year Growth Analysis

Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+120.0%
Year-over-Year
Equity Growth
+250.0%
Year-over-Year
Liabilities Growth
+120.0%
Year-over-Year
Financing Cash Flow Growth
+133.3%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023
Revenue 0 25 18 14
Expenses 0 20 16 13
EBITDA 0 5 2 1
Operating Profit Margin % 0.00% 20.00% 9.00% 4.00%
Depreciation 0 0 0 0
Interest 0 1 0 0
Profit Before Tax 0 4 1 0
Tax 0 1 0 0
Net Profit 0 3 1 0
Earnings Per Share (₹) 0.00 6.37 5.32 1.30

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023
ASSETS
Total Assets 22 10 6
Current Assets 20 8 6
Fixed Assets 1 1 1
Capital Work in Progress 0 0 0
Investments 0 0 0
Other Assets 21 9 6
LIABILITIES
Total Liabilities 22 10 6
Current Liabilities 3 4 2
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 7 2 1
Share Capital 5 0 0
Reserves & Surplus 2 2 1

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023
Operating Activities -2 -2 0
Investing Activities -1 0 0
Financing Activities 7 3 1
Net Cash Flow 4 0 0